This contract supports the advanced development of a of multivalent filovirus (Ebola and Marburg) vaccine through cGMP manufacturing with an option for a Phase 1 clinical trial. Additional options provide address Large Scale Production, development of a lyophilized formulation and a Phase 2 Clinical Trial. IBT's product has proven effective in various animal models and is in early preclinical evaluation.

Project Start
2008-09-30
Project End
2012-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2009
Total Cost
$6,180,074
Indirect Cost
Name
Integrated Biotherapeutics, Inc.
Department
Type
DUNS #
601000750
City
Gaithersburg
State
MD
Country
United States
Zip Code
20878